← Back

Wire · technology

TCS launches agentic AI platform for drug development

Published

17 August 2026

Topic

technology

Sectors

AI AgentsDrug DiscoveryBiotech

Source

Read at newindianexpress.com

Verified

Fusion42 · 17 August 2026 · Fusion42 review

TCS has launched TCS ADD AgentHub, an agentic AI platform that helps pharmaceutical companies improve efficiency in drug development and pharmacovigilance with integrated AI agents supporting clinical workflows and regulatory compliance.

This Wire brief sits within Fusion42's coverage of AI Agents, Drug Discovery and Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

You can deploy AI agents alongside your team to cut clinical data management time and costs without overhauling existing systems. This new platform makes AI integration in pharma workflows practical and compliant with tough regulations.

Related on Wire

Topics

AI AgentsDrug DiscoveryBiotechagentic-aidrug-developmentpharmaclinical-trialspharmacovigilance